Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lymphatic drainage pathway is not a molecular target but refers to the network of lymphatic vessels and nodes responsible for collecting interstitial fluid, proteins, immune cells, and waste from tissues and transporting them back to the bloodstream[2][4][8]. These routes are essential for maintaining tissue fluid balance, supporting immune surveillance, and facilitating the absorption of dietary fats. Lymphatic drainage pathways are also important in pathophysiological contexts, such as tumor metastasis (via lymphatic dissemination of cancer cells), lymphedema (when drainage is impaired), and infection spread[2][4][7]. The development and function of these pathways depend on specialized lymphatic endothelial cells with molecular markers including LYVE-1, PROX1, PDPN, VEGFR3, and CCL21[1][5][6]. Despite their critical biological roles, "lymphatic drainage pathways" is a structural/anatomical descriptor and not a conventional therapeutic molecular target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymphatic drainage pathway.